A S Ahmad1, S O Samuelsen. 1. Department of Obstetrics and Gynaecology and Medical Faculty Division, Akershus University Hospital, Lørenskog, Norway. aahs@ahus.no
Abstract
OBJECTIVE: To compare the proportion of offspring that was stillborn in pregnancies with pre-eclampsia, gestational hypertension or chronic hypertension with those in normotensive pregnancies. DESIGN: Register-based observational study. SETTING: The Medical Birth Registry of Norway. POPULATION: All singleton births after 20 completed weeks of gestation in Norway from 1967 to 2006 (n = 2 121 371). METHODS: The proportion of stillborn offspring was estimated in normotensive pregnancies, and in pregnancies with pre-eclampsia, gestational and chronic hypertension at different gestational lengths. In addition, changes in the proportions of stillborn offspring by maternal hypertensive disorder from 1967-1986 to 1987-2006 were estimated. MAIN OUTCOME MEASURES: Fetal death. RESULTS: The prevalence of hypertensive disorders in pregnancy was 4.7%. In total, 17 933 fetal deaths occurred and 9.2% of these were in hypertensive pregnancies. In normotensive pregnancies, 0.8% (16 290/2 022 400) experienced fetal death. This was true for 1.9% (1170/62 261) of the pregnancies with pre-eclampsia, 1.2% (390/32 068) with gestational hypertension and 1.8% (83/4642) with chronic hypertension. There was a 44% overall reduction in fetal death rate from 1967-1986 to 1987-2006. The largest decline was in women with pre-eclampsia (80% reduction). In women with gestational hypertension and chronic hypertension, the overall reductions in fetal death rates were 49% and 57%, respectively, comparable with the 41% decline in normotensive pregnancies. CONCLUSIONS: In our nationwide study during 1967-2006, the risk of fetal death among women with hypertensive disorders in pregnancy has been greatly reduced, especially among pre-eclamptic women at term. The risk of fetal death among women with gestational or chronic hypertension has also decreased, but in a different manner.
OBJECTIVE: To compare the proportion of offspring that was stillborn in pregnancies with pre-eclampsia, gestational hypertension or chronic hypertension with those in normotensive pregnancies. DESIGN: Register-based observational study. SETTING: The Medical Birth Registry of Norway. POPULATION: All singleton births after 20 completed weeks of gestation in Norway from 1967 to 2006 (n = 2 121 371). METHODS: The proportion of stillborn offspring was estimated in normotensive pregnancies, and in pregnancies with pre-eclampsia, gestational and chronic hypertension at different gestational lengths. In addition, changes in the proportions of stillborn offspring by maternal hypertensive disorder from 1967-1986 to 1987-2006 were estimated. MAIN OUTCOME MEASURES: Fetal death. RESULTS: The prevalence of hypertensive disorders in pregnancy was 4.7%. In total, 17 933 fetal deaths occurred and 9.2% of these were in hypertensive pregnancies. In normotensive pregnancies, 0.8% (16 290/2 022 400) experienced fetal death. This was true for 1.9% (1170/62 261) of the pregnancies with pre-eclampsia, 1.2% (390/32 068) with gestational hypertension and 1.8% (83/4642) with chronic hypertension. There was a 44% overall reduction in fetal death rate from 1967-1986 to 1987-2006. The largest decline was in women with pre-eclampsia (80% reduction). In women with gestational hypertension and chronic hypertension, the overall reductions in fetal death rates were 49% and 57%, respectively, comparable with the 41% decline in normotensive pregnancies. CONCLUSIONS: In our nationwide study during 1967-2006, the risk of fetal death among women with hypertensive disorders in pregnancy has been greatly reduced, especially among pre-eclamptic women at term. The risk of fetal death among women with gestational or chronic hypertension has also decreased, but in a different manner.
Authors: Karen J Gibbins; Robert M Silver; Halit Pinar; Uma M Reddy; Corette B Parker; Vanessa Thorsten; Marian Willinger; Donald J Dudley; Radek Bukowski; George R Saade; Matthew A Koch; Deborah Conway; Carol J Hogue; Barbara J Stoll; Robert L Goldenberg Journal: Placenta Date: 2016-05-07 Impact factor: 3.481
Authors: Lucia Cea Soriano; Brian T Bateman; Luis A García Rodríguez; Sonia Hernández-Díaz Journal: Pharmacoepidemiol Drug Saf Date: 2014-05-02 Impact factor: 2.890
Authors: Quaker E Harmon; Lisu Huang; David M Umbach; Kari Klungsøyr; Stephanie M Engel; Per Magnus; Rolv Skjærven; Jun Zhang; Allen J Wilcox Journal: Obstet Gynecol Date: 2015-03 Impact factor: 7.623